SIRT6 overexpression induces massive apoptosis in cancer cells but not in normal cells

Cell Cycle

Volumn 10, Issue 18, 2011, Pages 3153-3158

  Van Meter, Michael ^a   Mao, Zhiyong ^a   Gorbunova, Vera ^a   Seluanov, Andrei ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Cancer; DNA damage; p53; p73; SIRT6

Indexed keywords

NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN P53; PROTEIN P73; SIRTUIN 6;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER CELL DESTRUCTION; CANCER GENE THERAPY; CELL SURVIVAL; CONTROLLED STUDY; DRUG CYTOTOXICITY; ENZYME ACTIVITY; FEMALE; FIBROBLAST; FIBROSARCOMA; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; UTERINE CERVIX CARCINOMA;

EID: 80052908853     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.10.18.17435     Document Type: Article

References (26)

1. Mostoslavsky R, Chua KF, Lombard DB, Pang WW, Fischer MR, Gellon L, et al. Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell 2006; 124:315-29; PMID:16439206; DOI:10.1016/j.cell.2005.11.044.
2. Michishita E, McCord RA, Berber E, Kioi M, Padilla-Nash H, Damian M, et al. SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature 2008; 452:492-6; PMID:18337721; DOI:10.1038/nature06736.
3. McCord RA, Michishita E, Hong T, Berber E, Boxer LD, Kusumoto R, et al. SIRT6 stabilizes DNA-dependent protein kinase at chromatin for DNA double-strand break repair. Aging (Albany NY) 2009; 1:109-21; PMID:20157594.
4. Kaidi A, Weinert BT, Choudhary C, Jackson SP. Human SIRT6 promotes DNA end resection through CtIP deacetylation. Science 2010; 329:1348-53; PMID:20829486; DOI:10.1126/science.1192049.
5. Mao Z, Hine C, Tian X, Van Meter M, Au M, Vaidya A, et al. SIRT6 promotes DNA repair under stress by activating PARP1. Science 2011; 332:1443-6; PMID:21680843; DOI:10.1126/science.1202723.
6. Kawahara TL, Michishita E, Adler AS, Damian M, Berber E, Lin M, et al. SIRT6 links histone H3 lysine 9 deacetylation to NFkappaB-dependent gene expression and organismal life span. Cell 2009; 136:62-74; PMID:19135889; DOI:10.1016/j.cell.2008.10.052.
7. Zhong L, D'Urso A, Toiber D, Sebastian C, Henry RE, Vadysirisack DD, et al. The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha. Cell 2010; 140:280-93; PMID:20141841; DOI:10.1016/j.cell.2009.12.041.
8. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646-74; PMID:21376230; DOI:10.1016/j.cell.2011.02.013.
9. Pathak S, Multani AS, Furlong CL, Sohn SH. Telomere dynamics, aneuploidy, stem cells and cancer [review]. Int J Oncol 2002; 20:637-41; PMID:11836581.
10. Storchova Z, Pellman D. From polyploidy to aneuploidy, genome instability and cancer. Nat Rev Mol Cell Biol 2004; 5:45-54; PMID:14708009; DOI:10.1038/nrm1276.
11. Rayet B, Gelinas C. Aberrant rel/nfkb genes and activity in human cancer. Oncogene 1999; 18:6938-47; PMID:10602468; DOI:10.1038/sj.onc.1203221.
12. Chiao PJ, Na R, Niu J, Sclabas GM, Dong Q, Curley SA. Role of Rel/NFkappaB transcription factors in apoptosis of human hepatocellular carcinoma cells. Cancer 2002; 95:1696-705; PMID:12365017; DOI:10.1002/cncr. 10829.
13. Liszt G, Ford E, Kurtev M, Guarente L. Mouse Sir2 homolog SIRT6 is a nuclear ADP-ribosyltransferase. J Biol Chem 2005; 280:21313-20; PMID:15795229; DOI:10.1074/jbc.M413296200.
14. Mahlknecht U, Ho AD, Voelter-Mahlknecht S. Chromosomal organization and fluorescence in situ hybridization of the human Sirtuin 6 gene. Int J Oncol 2006; 28:447-56; PMID:16391800.
15. McGlynn LCJ, Edwards J, Shiels P. Evaluating the role of sirtuins 5, 6 & 7 in breast cancer. Cancer Research 2009; 69:3.
16. Ma W, Stafford LJ, Li D, Luo J, Li X, Ning G, et al. GCIP/CCNDBP1, a helix-loop-helix protein, suppresses tumorigenesis. J Cell Biochem 2007; 100:1376-86; PMID:17131381; DOI:10.1002/jcb.21140.
17. Zhong L, Mostoslavsky R. SIRT6: A master epigenetic gatekeeper of glucose metabolism. Transcr 2010; 1:17-21; PMID:21327158; DOI:10.4161/trns.1.1.12143.
18. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009; 324:1029-33; PMID:19460998; DOI:10.1126/science.1160809.
19. Das C, Lucia MS, Hansen KC, Tyler JK. CBP/p300-mediated acetylation of histone H3 on lysine 56. Nature 2009; 459:113-7; PMID:19270680; DOI:10.1038/nature07861.
20. Moll UM, Slade N. p63 and p73: roles in development and tumor formation. Mol Cancer Res 2004; 2:371-86; PMID:15280445.
21. Kanfi Y, Shalman R, Peshti V, Pilosof SN, Gozlan YM, Pearson KJ, et al. Regulation of SIRT6 protein levels by nutrient availability. FEBS Lett 2008; 582:543-8; PMID:18242175; DOI:10.1016/j.febslet.2008.01.019.
22. Longo VD, Fontana L. Calorie restriction and cancer prevention: metabolic and molecular mechanisms. Trends Pharmacol Sci 2010; 31:89-98; PMID:20097433; DOI:10.1016/j.tips.2009.11.004.
23. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003; 425:191-6; PMID:12939617; DOI:10.1038/nature01960.
24. Baker SJ, Markowitz S, Fearon ER, Willson JK, Vogelstein B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 1990; 249:912-5; PMID:2144057; DOI:10.1126/science.2144057.
25. Irwin M, Marin MC, Phillips AC, Seelan RS, Smith DI, Liu W, et al. Role for the p53 homologue p73 in E2F-1-induced apoptosis. Nature 2000; 407:645-8; PMID:11034215; DOI:10.1038/35036614.
26. Hine CM, Seluanov A, Gorbunova V. Use of the Rad51 promoter for targeted anti-cancer therapy. Proc Natl Acad Sci USA 2008; 105:20810-5; PMID:19106292; DOI:10.1073/pnas.0807990106.